Clinisys has integrated document intelligence into its Laboratory Solution platform, enabling labs to convert unstructured documents into searchable, governed data for improved workflow efficiency and reduced manual entry.
QIAGEN has launched QIAsymphony Connect, an IVD-compliant platform for automated nucleic acid extraction, supporting up to 96 samples per run and compatible with existing QIAsymphony reagents and consumables.
Clinical labs are adopting broader cancer diagnostics—including whole-genome sequencing and multi-omic testing—to deliver more comprehensive molecular insights and improve disease monitoring.
Diazyme Laboratories has acquired Carolina Liquid Chemistries, integrating CLC’s chemistry systems and reagents with Diazyme’s diagnostic technologies to expand solutions for reference and clinical laboratories.
Bio-Rad has launched Vericheck ddPCR kits for quality control in cell and gene therapy manufacturing, offering validated workflows for mycoplasma detection, capsid analysis, and residual DNA quantification.
Tactus AI debuted Elsie, an autonomous humanoid lab assistant designed to operate existing laboratory instruments using validated procedures, at the 2026 ADLM meeting, according to the company.
Using microfluidic shear stress, the system detaches living cells from excised tissue to support pathology workflows and downstream diagnostic testing.
Leica Biosystems received FDA 510(k) clearances for AI-assisted quality control software and two digital pathology scanners, including the first standalone tool to automate QC for digital slides in clinical workflows.
Emerging hazards like aerosolized chemicals and laser equipment demand upgraded protection.
Caresfield launched the Resilience-Ready Lab initiative at ADLM 2026, introducing products aimed at improving specimen integrity and supply chain resilience to help labs meet 2026 National Performance Goals.